Identifying Risk Factors and Developing a Predictive Model for Lymph Node Metastasis in Clinical Stage IA Peripheral Non-Small Cell Lung Cancer: A Retrospective Analysis - Top-Institutions - MDSpire

Identifying Risk Factors and Developing a Predictive Model for Lymph Node Metastasis in Clinical Stage IA Peripheral Non-Small Cell Lung Cancer: A Retrospective Analysis

  • By

  • Zhimao Chen

  • Yaokun Wang

  • Minghui Shi

  • Kang Qi

  • Xiangzheng Liu

  • Shijie Zhang

  • November 10, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Surgery
    • Medical Oncology
    • Pulmonary Medicine

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Surgery
    • Medical Oncology
    • Radiation Oncology

  • #3

    Peking University First Hospital
    Peking University First Hospital

    Beijing, Beijing

    Key Differentiators

    • Thoracic Surgery
    • Oncology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Thoracic Surgery
    • Pulmonology
    • Oncology

  • #5

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Thoracic Surgery
    • Medical Oncology

Original Source(s)

Identifying Risk Factors and Developing a Predictive Model for Lymph Node Metastasis in Clinical Stage IA Peripheral Non-Small Cell Lung Cancer: A Retrospective Analysis

  • by Zhimao Chen, Yaokun Wang, Minghui Shi, Kang Qi, Xiangzheng Liu, Shijie Zhang

  • November 10, 2025

Related Content

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study